Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. Read more


Researchers at the University of California San Diego have taken a step toward that goal by developing nano-sized vessels that could be filled with drug molecules and controlled with magnets for guided delivery to specific tissues and organs. Read more

Workshop will discuss accelerated preclinical drug development and readying molecules for phase I Read more


Scientists at the Technical University of Munich (TUM) have developed a small, highly active molecule that binds to a specific integrin which operates in many types of cancer Read more